A MESSAGE TO READERS
Subscribe to NCI's YouTube Channel
The latest videos from NCI—including videos featured in the NCI Cancer Bulletin—are now available on YouTube via the NCIgov channel. Access the channel from the YouTube icon in the navigation box on the right.
NEWS
Melanoma Drugs Have Unintended Effects in Some Tumors
Some patients with advanced melanoma have had dramatic responses to a new class of targeted drugs in early stage clinical trials. While the long-term effects of these drugs, called BRAF inhibitors, are not yet known, two reports suggest that these drugs may have unintended consequences in patients whose tumors lack mutations in the BRAF gene. Read more > >
Symptoms of Ovarian Cancer May Not Help Early Detection
The symptoms are fairly nonspecific and the disease is rareTrastuzumab Benefits Women with Locally Advanced, Inflammatory Breast Cancer
Giving the drug before and after surgery may reduce tumor growth and recurrenceTumor-targeting Antibodies Against Glycoproteins May Be Markers of Early Cancer
Autoantibodies found in patients with cancer but not in healthy control subjectsGene Mutation Linked to Poor Survival in Children with Medulloblastoma
Finding may explain why some patients with good prognosis still don't fare well
COMMENTARY
Guest Director's Update: Join the Cancer.gov Evolution
by Dr. Lenora Johnson
We all know the cliché, but it's true nevertheless: We live in a small world, one that seems to get smaller with each new technological advance. Almost immediately after the tragic earthquake in Haiti, for instance, smart phones, Twitter feeds, and blogs were literally buzzing with the news, and almost as quickly people responded with aid, often using these same communication tools. Even now, in the midst of record snow storms blanketing the nation's capital, NCI's ability to communicate vital information is hardly affected. Read more > >
IN DEPTH
Experts Recommend Steps to Increase Colorectal Cancer Screening in Primary Care
Panel identifies screening barriers that need to be addressed
Profiles in Cancer Research: Dr. Raju Kucherlapati
The Harvard geneticist's work has been instrumental in the era of personalized medicine
Cancer Center Profile: The University of Texas M. D. Anderson Cancer Center
One of the country's oldest and largest cancer centers continues to expand with new programs
Featured Clinical Trial: Optimizing Chemotherapy with Bevacizumab for Ovarian Cancer
What is the best way to give chemotherapy and bevacizumab for ovarian cancer?
Operation Cessation: Curbing Military and Veteran Tobacco Use
The DoD and VA are tailoring programs to support quit attempts
UPDATES
FDA Update
- Another Use for the Cancer Drug Lapatinib
NIH Update
- NIH Clinical Center to Track Radiation Doses from Diagnostic Imaging
Cancer.gov Update
- Online Course for Health Professionals on Clinical Trials
Notes
- NCI's Dr. Robert Wiltrout Named FLC's Lab Director of the Year
- Learn about NCI's Cancer Biobank at caHUB Public Information Meetings
- NCI Symposium Will Look at Translational Genomics
- World Cancer Day Observed on February 4
- NCI and AACC Partner to Bridge Gap between Lab and Clinic
Selected articles from past issues of the NCI Cancer Bulletin are available in Spanish.
The NCI Cancer Bulletin is produced by the National Cancer Institute (NCI), which was established in 1937. Through basic, clinical, and population-based biomedical research and training, NCI conducts and supports research that will lead to a future in which we can identify the environmental and genetic causes of cancer, prevent cancer before it starts, identify cancers that do develop at the earliest stage, eliminate cancers through innovative treatment interventions, and biologically control those cancers that we cannot eliminate so they become manageable, chronic diseases.
For more information about cancer, call 1-800-4-CANCER or visit http://www.cancer.gov.
NCI Cancer Bulletin staff can be reached at ncicancerbulletin@mail.nih.gov.
